Prepared for:

Agency for Healthcare Research and Quality

U.S. Department of Health and Human Services

540 Gaither Road

Rockville, MD 20850

www.ahrq.gov

Contract No. 290-02-0026

Prepared by:

Blue Cross and Blue Shield Association

Technology Evaluation Center Evidence-based Practice Center (EPC)

Chicago, Illinois

Investigators

Margaret Piper, Ph.D., M.P.H., Principal Investigator

Jerome Seidenfeld, Ph.D.

Naomi Aronson, Ph.D., EPC Director

AHRQ Publication No. 04-E017-2

August 2004

ISBN: 1-58763-165-2

ISSN: 1530-4396

This document is in the public domain and may be used and reprinted without permission except those copyrighted materials noted for which further reproduction is prohibited without the specific permission of copyright holders.

This report may be used, in whole or in part, as the basis for development of clinical practice guidelines and other quality enhancement tools, or a basis for reimbursement and coverage policies. AHRQ or U.S. Department of Health and Human Services endorsement of such derivative products may not be stated or implied.

AHRQ is the lead Federal agency charged with supporting research designed to improve the quality of health care, reduce its cost, address patient safety and medical errors, and broaden access to essential services. AHRQ sponsors and conducts research that provides evidence-based information on health care outcomes; quality; and cost, use, and access. The information helps health care decisionmakers - patients and clinicians, health system leaders, and policymakers - make more informed decisions and improve the quality of health care services.

Suggested Citation:

Piper M, Seidenfeld J, Aronson N. Islet Transplantation in Patients with Type 1 Diabetes Mellitus. Evidence Report/Technology Assessment No. 98 (Prepared by Blue Cross and Blue Shield Association Technology Evaluation Center Evidence-based Practice Center under Contract No. 290-02-0026). AHRQ Publication 04-E017-2. Rockville, MD: Agency for Healthcare Research and Quality. August 2004